Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 2, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
AstraZeneca’s Triple Therapy BREZTRI Shows Promise in Phase III Asthma Trials
Life Sciences Times
-
May 2, 2025
Pharma
QPS India Successfully Completes Unscheduled US FDA Inspection, Reinforces Global Compliance Standards
Life Sciences Times
-
May 1, 2025
Pharma
Astria Therapeutics Publishes Promising Phase 1a Data on Navenibart in Leading Allergy Journal
Life Sciences Times
-
May 1, 2025
Pharma
Strand Therapeutics Unveils Promising Preclinical Data for STX-003, a Programmable mRNA Therapy Targeting Solid Tumors
Life Sciences Times
-
April 29, 2025
Pharma
Barth Syndrome Foundation Urges FDA to Act Swiftly on Delayed Elamipretide Decision
Life Sciences Times
-
April 29, 2025
Pharma
LifeMine Begins First-in-Human Clinical Trial for Groundbreaking Immunosuppressive Drug LIFE-001
Life Sciences Times
-
April 8, 2025
0
Pharma
KalVista Partners with Kaken Pharmaceutical to Bring First Oral HAE Treatment to Japan
Life Sciences Times
-
April 8, 2025
0
Pharma
FDA Rejects Aldeyra Therapeutics’ Resubmission for Dry Eye Drug Reproxalap
Life Sciences Times
-
April 3, 2025
0
Pharma
Palleon Pharmaceuticals and Henlius Receive NMPA Approval for Phase 2 Trial of E-602 in Autoimmune Diseases
Life Sciences Times
-
April 2, 2025
0
Pharma
Cycle Vita Expands Multiple Sclerosis Patient Support to Include BAFIERTAM
Life Sciences Times
-
March 31, 2025
0
Pharma
Arbutus Biopharma Implements Significant Workforce Reduction as Part of Strategic Restructuring
Life Sciences Times
-
March 31, 2025
0
Pharma
European Commission Approves Merck’s CAPVAXIVE® Vaccine for Prevention of Pneumococcal Disease in Adults
Life Sciences Times
-
March 31, 2025
0
Pharma
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Mortality, Hospitalizations, and Urgent Heart Failure in Patients with ATTR-CM
Life Sciences Times
-
March 23, 2025
0
Pharma
Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection
Life Sciences Times
-
March 23, 2025
0
Pharma
New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria
Life Sciences Times
-
March 18, 2025
0
Pharma
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
Life Sciences Times
-
March 17, 2025
0
Pharma
Shorla Oncology Announces Expansion of U.S. Commercial Footprint with Launch of Dedicated Sales Force and Market Access Teams
Life Sciences Times
-
March 4, 2025
0
1
2
3
4
...
63
Page 3 of 63
Most Read
Aktiia Raises $42 Million in Series B and Rebrands as Hilo to Expand Global Blood Pressure Monitoring
May 2, 2025
Virgo Unveils EndoML, a New AI Platform for Gastroenterology Research, at DDW 2025
May 2, 2025
Blue Cross Blue Shield of Massachusetts Offers Free $50 Bluebikes Credit for National Bike Month
May 2, 2025
Turn Therapeutics Achieves Breakthrough in Vaccine Stability, Opening Door to Cold-Chain-Free Delivery
May 2, 2025